Icosavax, Inc. announced it raised $99.7 Million in an initial filing from an offering of $99.7 Million
Icosavax, Inc. announced it raised $99.7 Million in an initial filing from an offering of $99.7 Million
04/07/21, 7:31 PM
Location
seattleMoney raised
$99.7 million
Industry
biotechnology
Company Info
Location
1616 eastlake ave. e, ste. 208
seattle, washington, united states
Additional Info
Computationally Designed VLP Vaccines
Computationally designed proteins that self-assemble into virus-like particles (VLPs), we are able to readily manufacture VLPs displaying complex antigens to target significant unmet medical needs. Protect from respiratory syncytial virus (RSV) disease.